Send the following on WhatsApp
Continue to ChatBleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction - https://avesis.marmara.edu.tr/yayin/2976f60b-9f74-491d-a4ea-2d9171974463/bleeding-risk-with-concomitant-use-of-tirofiban-and-third-generation-p2y12-receptor-antagonists-in-patients-with-acute-myocardial-infarction